Akt activation promotes degradation of tuberin and FOXO3a via the proteasome

David R Plas1, Craig B Thompson

  • 1Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylania 19104, USA.

Insights

Activated Akt (a protein kinase) triggers the proteasomal degradation of its substrates, promoting cell growth and survival. This process involves the breakdown of negative regulators, leading to enhanced cell proliferation and survival.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Growth factor receptors are crucial for cell growth and survival.
  • They activate phosphatidylinositol 3-kinase and Akt/PKB signaling pathways.
  • Understanding Akt's downstream effects is key to cellular regulation.

Purpose of the Study:

  • To investigate the role of Akt activation in protein degradation.
  • To identify Akt substrates targeted for proteasomal degradation.
  • To elucidate the mechanism of Akt-mediated cell growth and survival.

Main Methods:

  • Expression of activated Akt in cellular models.
  • Utilizing proteasome inhibitors to assess protein stability.
  • Analyzing protein levels and ubiquitination status of Akt substrates.
  • Western blotting and immunoprecipitation techniques.

Main Results:

  • Activated Akt induced proteasome-dependent degradation of tuberin, FOXO1, and FOXO3a.
  • Proteasome inhibitors stabilized phosphorylated Akt substrates.
  • Akt activation led to ubiquitination of proteins with phosphorylated Akt substrate motifs.

Conclusions:

  • Activated Akt promotes cell growth and survival via proteasomal degradation of its substrates.
  • This degradation targets negative regulators of cell growth and survival.
  • Akt-mediated proteolysis is a critical mechanism in cellular regulation.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...